drugset / Trial / NCT04497649
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
efficacy and safety of Sofosbuvir containing regimens in treatment of COVID-19 Egyptian patients,
Timeline
- Start
- 2020-07-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daclatasvir | Small molecule | — | — |
| Subject | Sofosbuvir | Small molecule | — | — |